Home > Drug Search >
  • Targets: Adenosine triphosphatase (ATPase)
  •   > 
Drug Filter
Category:
chemistry (7) biology (9)
Status:
Approved (2) BLA Filing (1) Phase Ⅱ (10) Phase Ⅰ (3)
Clinical Stage:
Pending (1) Active (10) Discontinued (3)
Bio-Type:
Recombinant cytokines (3) Whole antibody (2) Single-domain antibody (Nanobody) (1) Fusion protein (2)
Company:
GlaxoSmithKline (1) Merck Sharp & Dohme (1) Philogen (1) Roche (1) Sun Pharmaceutical (1) REPLICor (3) Unknown (1) Celonic (1) Baliopharm AG (1) Apoxis (1) Edimer (1) Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (1) ETX Pharma (1) Green Cross (1) Medicines for Malaria Venture (1) Lycera (1) MolMed (1) Boehringer Ingelheim (1) Celgene (1)
Indication:
Breast cancer (1) Crohn's disease (1) HBV infection (5) Inflammatory bowel disease (1) Melanoma (1) Ectodermal dysplasia (1) Soft tissue sarcoma (1) Solid tumours (1) Ulcerative colitis (1) Colorectal cancer (1) Acute Lung Injury (1) Sarcoma (1) Malaria (1) Disseminated intravascular coagulation (DIC) (1) Esophageal adenocarcinoma (1) HDV infection (1) Acute pancreatitis (1) Mesothelioma (1) Inflammation (1)
Aprv. Year:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top